Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
The pressure to find treatments and preventions for Alzheimer's disease has been building steadily over the past decade, and it's becoming critical as the United States prepares for the crush of Baby Boomers who are approaching their 70s, when the disease is most likely to strike.
Shinya Yamanaka, who won the Nobel Prize last year and who bridges two countries with labs at Kyoto University and the Gladstone Institutes in San Francisco, was honored when the Japan-based Alliance Forum Foundation brought its meeting to San Francisco last Friday. Throughout the day Yamanaka’s prize-winning idea for reprogramming adult cells into embryonic-like stem cells was referred to as game changing for all of biology.
Scientists have discovered that the human body contains more than 25,000 genes, but what they do remains mostly a mystery. “We don’t know the function of the vast majority of genes,” says Nevan Krogan, PhD, Gladstone Investigator and director of the UC San Francisco branch of the California Institute for Quantitative Biosciences.
Yamanaka, who is a Gladstone Institutes Investigator, worked with CIRM training grant recipient Kathleen Worringer to find a way of improving the efficiency of the technique. They published their results in the November 14 issue of Cell Stem Cell.
Every mother transmits a secondgenetic legacy to her children and her children’s children, via mitochondrial DNA. Locked within it may be the key to destructive disease or a chance to alter future generations.
New genetic research has revealed the existence of certain regions in the human genome that have changed or mutated more rapidly than most others, resulting in differences that make us human among our primate cousins.
This week at a conference hosted by the journals Cell and The Lancet, Gladstone's Warner C. Greene discussed studies that for the first time mechanistically link the two pathogenic signatures of HIV infection: CD4 T cell depletion and chronic inflammation.
Chronicle columnist Leah Garchik comments on Dagmar Dolby's presentation of the 2013 Pacesetter Award to Gladstone's Lennart Mucke—for his lifelong dedication to overcoming Alzheimer’s disease—at last week's ARCS Scholar Luncheon.
Gladstone's Lennart Mucke and Keith Vossel are featured in an article about the growing body of research into the connection between Alzheimer’s disease and epilepsy—research that is providing hope for the 5 million patients currently suffering from the disease.
Gladstone's Warner C. Greene joins with other HIV/AIDS experts to discuss the possibility of curing HIV/AIDS, in a videotape of an October event in San Francisco.